SCHEMBL39935

SCHEMBL39935

CN1CCN(CCNC(=O)c2[nH]c3ccc(Cl)cc3c2-c2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
KDM4E B2RXH2 3/20 0.62
MAPT P10636 2/20 0.59
POLB P06746 1/20 0.59
MAP2 P11137 4/20 0.56
GAA P10253 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
HPGD P15428 2/20 0.53
CYP1A2 P05177 1/20 0.53
XBP1 P17861 1/20 0.53
CYP2C19 P33261 1/20 0.53
MDM4 O15151 2/20 0.53
BCL2L1 Q07817 1/20 0.52
CNR2 P34972 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ATM Q13315 1/20 0.51
TP53 P04637 1/20 0.51
MDM2 Q00987 1/20 0.51
CNR1 P21554 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39921 0.89 CNR2 (0.50) ALDH1A1KDM4EMAPTPOLBMAP2
SCHEMBL13151482 0.88 MAP2 (0.51) ALDH1A1KDM4EMAPTPOLBMAP2
SCHEMBL39858 0.87 CNR2 (0.49) ALDH1A1KDM4EMAPTPOLBMAP2
SCHEMBL39949 0.86 CNR2 (0.49) ALDH1A1KDM4EMAP2GAAHPGD
SCHEMBL40013 0.84 CNR2 (0.55) ALDH1A1KDM4EMAP2GAAHPGD
SCHEMBL39881 0.82 CNR2 (0.47) ALDH1A1KDM4EPOLBMAP2GAA
SCHEMBL18092652 0.80 MAP2 (0.65) ALDH1A1KDM4EMAPTPOLBMAP2
SCHEMBL6356091 0.78 ALDH1A1 (0.74) ALDH1A1KDM4EMAPTPOLBMAP2
SCHEMBL4934962 0.78 MDM4 (0.55) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL11740534 0.77 MDM4 (0.54) ALDH1A1KDM4EHPGDCYP2C19MDM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419408-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K. (JP) 2012-02-22 EP claimed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US claimed
WO-2010119984-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-10-21 WO claimed
EP-2419408-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K. (JP) 2012-02-22 EP disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
WO-2010119984-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-10-21 WO disclosed
WO-2010119984-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE IDO1, TPH1, AHR ALDH1A1 2066/4885KDM4E 2947/4885MAPT 3630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.